Relay Therapeutics, Inc. Stock, NASDAQ:RLAY
399 Binney Street, 2nd floor, Cambridge, Massachusetts 02139
United States of America
Number of Employees: 122
Relay Therapeutics, Inc. is a clinical-stage precision medicines company. It focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets. The company was founded by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is headquartered in Cambridge, MA.